MESO Q1 2018 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+197.2% YoY

Gross Profit

$297,00025.3% margin

Operating Income

-$20M-1710.6% margin

Net Income

-$7M-598.1% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+107.4%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$672M

Total Liabilities

$112M

Stockholders' Equity

$560M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$395,000	+197.2%
Gross Profit	$297,000	-$3M	+110.2%
Operating Income	-$20M	-$22M	+8.3%
Net Income	-$7M	-$20M	+64.5%